Staff members at the United States’s premier infectious-disease research institute, the National Institute of Allergy and Infectious Diseases (NIAID), have recently been instructed to remove the words “biodefense” and “pandemic preparedness” from the institute’s web pages. This directive is part of a broader shake-up at the NIAID, one of 27 institutes and centers at the National Institutes of Health (NIH). The NIAID is expected to deprioritize research projects related to biodefense and pandemic preparedness, according to sources who spoke to Nature on the condition of anonymity.
NIH director Jay Bhattacharya announced the restructuring of the NIAID at an event with other top agency officials. He stated that the institute will shift its focus away from traditional priorities such as HIV, biodefense, and pandemic preparedness. Instead, the NIAID will concentrate more on basic immunology and other infectious diseases currently affecting people in the United States, rather than predicting future diseases.
Currently, about one-third of the NIAID’s $6.6 billion budget funds projects involving emerging infectious diseases and biodefense. This research includes studying pathogens of concern, monitoring their spread, and developing medical countermeasures against threats from radiation exposure, chemicals, and infectious diseases.
Nahid Bhadelia, director of Boston University’s Center on Emerging Infectious Diseases, expressed concern that deprioritizing biodefense and pandemic preparedness areas will leave the United States vulnerable to evolving pathogens and potential outbreaks. She emphasized that ignoring these issues does not make them disappear but rather makes the country less prepared.
In response to queries about the restructuring, an NIH spokesperson highlighted the institute’s new vision to focus on infectious diseases and immunology, addressing pressing health challenges faced by Americans today. However, specific details about the agency’s plans to restructure the NIAID were not provided.
The NIAID’s leadership has recently undergone changes, with acting director Jeffery Taubenberger leading the institute after the dismissal of previous director Jeanne Marrazzo. Marrazzo was fired by the Trump administration following scrutiny over public health measures implemented during the COVID-19 pandemic.
To restore trust and implement the new vision for the institute, Bhattacharya, Taubenberger, and senior adviser John Powers outlined their plans in a commentary published in Nature Medicine. They emphasized the need for a shift in research focus and urgency in addressing allergic, autoimmune disorders, and common infections.
The NIAID employees stated that the instructions to rebrand the institute’s language are just the beginning of the implementation of the new vision. Further changes, including a review of grants funding biodefense and pandemic preparedness, are expected in the coming weeks and months.
The reallocation of funds away from biodefense and pandemic preparedness research could have significant consequences, as few other US agencies have the resources to support basic research in these critical areas. Experts like Gigi Gronvall, a biosecurity specialist at Johns Hopkins Bloomberg School of Public Health, argue that studying potential threats like viruses is essential for preparedness.
In conclusion, the NIAID’s shift in research priorities has sparked debate and concern among experts in the field. While the new focus on infectious diseases and immunology is important, some argue that neglecting biodefense and pandemic preparedness research could leave the country vulnerable to future health crises. The impact of these changes on public health and research remains to be seen as the NIAID moves forward with its restructuring plans. The recent restructure at the National Institute of Allergy and Infectious Diseases (NIAID) has left employees feeling uncertain about their future. The NIH spokesperson has declined to provide any information regarding the possibility of further layoffs within the NIAID staff, adding to the anxiety and concern among institute employees.
According to a source within the institute, “Everyone is worried about what comes next.” The lack of transparency from management has created a sense of unease and insecurity among staff members. Many are unsure if their positions are secure or if they will be affected by any upcoming changes.
The restructure at NIAID has been a topic of discussion and speculation among employees since it was first announced. With no clear communication from higher-ups, employees are left to wonder about the potential impact on their jobs and the overall functioning of the institute.
As the situation continues to unfold, employees are bracing themselves for any potential changes that may come their way. The uncertainty surrounding the restructure has created a tense atmosphere within NIAID, with many employees feeling on edge about what the future holds.
It is crucial for management to provide clear and timely communication to employees during times of organizational change. Transparency and open dialogue can help alleviate fears and uncertainties, allowing employees to better understand their role within the institute and what to expect moving forward.
As the situation at NIAID continues to develop, employees are hopeful for more clarity and information from management. The wellbeing of staff members is vital during times of change, and it is important for the institute to prioritize communication and support for its employees during this challenging period.
This article was originally published on February 13, 2026, and has been reproduced with permission. For more information on the restructure at NIAID, please visit the original article here.
